# A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder

> **NCT04504253** · PHASE3 · COMPLETED · sponsor: **University of Utah** · enrollment: 18 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Creatine monohydrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04504253
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-03
- **Primary completion:** 2023-08-02
- **Final completion:** 2023-08-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04504253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04504253, "A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04504253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*